{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:34:54Z","timestamp":1790789694449,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pronounced immune escape by the SARS-CoV-2 Omicron variant has resulted in many individuals possessing hybrid immunity, generated through a combination of vaccination and infection. Concerns have been raised that omicron breakthrough infections in triple-vaccinated individuals result in poor induction of omicron-specific immunity, and that prior SARS-CoV-2 infection is associated with immune dampening. Taking a broad and comprehensive approach, we characterize mucosal and blood immunity to spike and non-spike antigens following BA.1\/BA.2 infections in triple mRNA-vaccinated individuals, with and without prior SARS-CoV-2 infection. We find that most individuals increase BA.1\/BA.2\/BA.5-specific neutralizing antibodies following infection, but confirm that the magnitude of increase and post-omicron titres are higher in the infection-naive. In contrast, significant increases in nasal responses, including neutralizing activity against BA.5 spike, are seen regardless of infection history. Spike-specific T cells increase only in infection-naive vaccinees; however, post-omicron T cell responses are significantly higher in the previously-infected, who display a maximally induced response with a highly cytotoxic CD8+ phenotype following their 3\n                    <jats:sup>rd<\/jats:sup>\n                    mRNA vaccine dose. Responses to non-spike antigens increase significantly regardless of prior infection status. These findings suggest that hybrid immunity induced by omicron breakthrough infections is characterized by significant immune enhancement that can help protect against future omicron variants.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-40592-4","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T09:02:50Z","timestamp":1692608570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-9743","authenticated-orcid":false,"given":"Hailey","family":"Hornsby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-3819","authenticated-orcid":false,"given":"Alexander R.","family":"Nicols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-431X","authenticated-orcid":false,"given":"Stephanie","family":"Longet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Angyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0867-2867","authenticated-orcid":false,"given":"Barbara","family":"Kronsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Tyerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyada","family":"Supasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeswaran","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-7390","authenticated-orcid":false,"given":"Isabel","family":"Neale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-7715","authenticated-orcid":false,"given":"Natalie A.","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Nell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Grouneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Rostron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-2806","authenticated-orcid":false,"given":"Shona C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagida","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthathip","family":"Mongkolsapaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-897X","authenticated-orcid":false,"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wootton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-4277","authenticated-orcid":false,"given":"Victoria","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-0831","authenticated-orcid":false,"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-4309","authenticated-orcid":false,"given":"Gavin","family":"Screaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The PITCH Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0778-1693","authenticated-orcid":false,"given":"Lance","family":"Turtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Rowland-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5665-6293","authenticated-orcid":false,"given":"Susanna J.","family":"Dunachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-7367","authenticated-orcid":false,"given":"Rebecca P.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-9212","authenticated-orcid":false,"given":"Thushan I.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"40592_CR1","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1126\/science.abn8347","volume":"375","author":"P Elliott","year":"2022","unstructured":"Elliott, P. et al. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science 375, 1406\u20131411 (2022).","journal-title":"Science"},{"key":"40592_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana, R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679\u2013686 (2022).","journal-title":"Nature"},{"key":"40592_CR3","unstructured":"UKHSA. UK Health Security Agency SARS-CoV-2 variants of concern and variants under investigation in England. Technical Briefing 48. (UKHSA, 2022)."},{"key":"40592_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1126\/science.abq0203","volume":"377","author":"JE Bowen","year":"2022","unstructured":"Bowen, J. E. et al. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines. Science 377, 890\u2013894 (2022).","journal-title":"Science"},{"key":"40592_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"40592_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) Variant. N. Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"key":"40592_CR7","doi-asserted-by":"publisher","unstructured":"Frei, A. et al. Development of hybrid immunity during a period of high incidence of infections with Omicron subvariants: A prospective population based multi-region cohort study. Preprint at https:\/\/doi.org\/10.1101\/2022.10.14.22281076 (2022).","DOI":"10.1101\/2022.10.14.22281076"},{"key":"40592_CR8","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2666-5247(21)00275-5","volume":"3","author":"A Angyal","year":"2022","unstructured":"Angyal, A. et al. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. Lancet Microbe 3, e21\u2013e31 (2022).","journal-title":"Lancet Microbe"},{"key":"40592_CR9","doi-asserted-by":"publisher","unstructured":"Moore, S. C. et al. Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study. Preprint at https:\/\/doi.org\/10.1101\/2022.06.06.22275865 (2022).","DOI":"10.1101\/2022.06.06.22275865"},{"key":"40592_CR10","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1016\/j.cell.2021.10.011","volume":"184","author":"RP Payne","year":"2021","unstructured":"Payne, R. P. et al. Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell 184, 5699\u20135714.e11 (2021).","journal-title":"Cell"},{"key":"40592_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41577-022-00678-4","volume":"22","author":"A Sigal","year":"2022","unstructured":"Sigal, A. Milder disease with Omicron: is it the virus or the pre-existing immunity? Nat. Rev. Immunol. 22, 69\u201371 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"40592_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(22)00362-0","volume":"22","author":"K Blom","year":"2022","unstructured":"Blom, K. et al. Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection. Lancet Infect. Dis. 22, 943\u2013945 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"40592_CR13","doi-asserted-by":"publisher","first-page":"eabq1841","DOI":"10.1126\/science.abq1841","volume":"377","author":"CJ Reynolds","year":"2022","unstructured":"Reynolds, C. J. et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science 377, eabq1841 (2022).","journal-title":"Science"},{"key":"40592_CR14","unstructured":"Department of Health and Social Care UK. Optimising the COVID-19 vaccination programme for maximum short-term impact. https:\/\/www.gov.uk\/government\/publications\/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement\/optimising-the-covid-19-vaccination-programme-for-maximum-short-term-impact (Department of Health and Social Care UK, 2021)."},{"key":"40592_CR15","unstructured":"COG-UK Mutation Explorer. http:\/\/sars2.cvr.gla.ac.uk\/cog-uk\/ (2022)."},{"key":"40592_CR16","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/eji.201343751","volume":"43","author":"YD Mahnke","year":"2013","unstructured":"Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M. & Lugli, E. The who\u2019s who of T-cell differentiation: Human memory T-cell subsets. Eur. J. Immunol. 43, 2797\u20132809 (2013).","journal-title":"Eur. J. Immunol."},{"key":"40592_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1126\/science.adc9127","volume":"378","author":"Y-J Park","year":"2022","unstructured":"Park, Y.-J. et al. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science 378, 619\u2013627 (2022).","journal-title":"Science"},{"key":"40592_CR18","first-page":"572","volume":"104","author":"T Francis","year":"1960","unstructured":"Francis, T. On the doctrine of original antigenic sin. Proc. Am. Philos. Soc. 104, 572\u2013578 (1960).","journal-title":"Proc. Am. Philos. Soc."},{"key":"40592_CR19","doi-asserted-by":"publisher","first-page":"17221","DOI":"10.1073\/pnas.1920321117","volume":"117","author":"CP Arevalo","year":"2020","unstructured":"Arevalo, C. P. et al. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies. Proc. Natl Acad. Sci. 117, 17221\u201317227 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"40592_CR20","doi-asserted-by":"publisher","first-page":"e1008109","DOI":"10.1371\/journal.ppat.1008109","volume":"15","author":"KM Gostic","year":"2019","unstructured":"Gostic, K. M. et al. Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLOS Pathog. 15, e1008109 (2019).","journal-title":"PLOS Pathog."},{"key":"40592_CR21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/cid\/ciy327","volume":"67","author":"M Kosikova","year":"2018","unstructured":"Kosikova, M. et al. Imprinting of repeated influenza A\/H3 exposures on antibody quantity and antibody quality: implications for seasonal vaccine strain selection and vaccine performance. Clin. Infect. Dis. 67, 1523\u20131532 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"40592_CR22","doi-asserted-by":"publisher","first-page":"111496","DOI":"10.1016\/j.celrep.2022.111496","volume":"41","author":"EM Anderson","year":"2022","unstructured":"Anderson, E. M. et al. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Rep. 41, 111496 (2022).","journal-title":"Cell Rep."},{"key":"40592_CR23","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.cell.2022.09.032","volume":"185","author":"CM Buckner","year":"2022","unstructured":"Buckner, C. M. et al. Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses. Cell 185, 4333\u20134346.e14 (2022).","journal-title":"Cell"},{"key":"40592_CR24","doi-asserted-by":"publisher","first-page":"953949","DOI":"10.3389\/fimmu.2022.953949","volume":"13","author":"S Longet","year":"2022","unstructured":"Longet, S. et al. mRNA vaccination drives differential mucosal neutralizing antibody profiles in na\u00efve and SARS-CoV-2 previously-infected individuals. Front. Immunol. 13, 953949 (2022).","journal-title":"Front. Immunol."},{"key":"40592_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32389-8","volume":"13","author":"K Sano","year":"2022","unstructured":"Sano, K. et al. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat. Commun. 13, 5135 (2022).","journal-title":"Nat. Commun."},{"key":"40592_CR26","doi-asserted-by":"publisher","unstructured":"Liew, F. et al. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine 104402 https:\/\/doi.org\/10.1016\/j.ebiom.2022.104402 (2022).","DOI":"10.1016\/j.ebiom.2022.104402"},{"key":"40592_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.medj.2022.09.010","volume":"3","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection. Med 3, 838\u2013847.e3 (2022).","journal-title":"Med"},{"key":"40592_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cei\/uxac042","volume":"209","author":"E Phillips","year":"2022","unstructured":"Phillips, E. et al. Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in na\u00efve and convalescent healthcare workers. Clin. Exp. Immunol. 209, 90\u201398 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"40592_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm0402-379","volume":"8","author":"V Appay","year":"2002","unstructured":"Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379\u2013385 (2002).","journal-title":"Nat. Med."},{"key":"40592_CR30","doi-asserted-by":"publisher","first-page":"e162282","DOI":"10.1172\/JCI162282","volume":"132","author":"T Dangi","year":"2022","unstructured":"Dangi, T. et al. Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody. J. Clin. Invest 132, e162282 (2022).","journal-title":"J. Clin. Invest"},{"key":"40592_CR31","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/eji.202149470","volume":"52","author":"K Hagemann","year":"2022","unstructured":"Hagemann, K. et al. Natural killer cell\u2010mediated ADCC in SARS\u2010CoV\u20102\u2010infected individuals and vaccine recipients. Eur. J. Immunol. 52, 1297\u20131307 (2022).","journal-title":"Eur. J. Immunol."},{"key":"40592_CR32","doi-asserted-by":"publisher","unstructured":"Whitaker, H. J. et al. Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off. Preprint at https:\/\/doi.org\/10.1101\/2021.10.25.21264964 (2021).","DOI":"10.1101\/2021.10.25.21264964"},{"key":"40592_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJMc2209479","volume":"387","author":"J Malato","year":"2022","unstructured":"Malato, J. et al. Risk of BA.5 infection among Persons exposed to previous SARS-CoV-2 variants. N. Engl. J. Med. 387, 953\u2013954 (2022).","journal-title":"N. Engl. J. Med."},{"key":"40592_CR34","doi-asserted-by":"publisher","unstructured":"Hansen, C. H. et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a Danish nation-wide population-based study. SSRN Electron. J. https:\/\/doi.org\/10.2139\/ssrn.4165630 (2022).","DOI":"10.2139\/ssrn.4165630"},{"key":"40592_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa2203965","volume":"387","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh, H. N. et al. Effects of previous infection and vaccination on symptomatic omicron infections. N. Engl. J. Med. 387, 21\u201334 (2022).","journal-title":"N. Engl. J. Med."},{"key":"40592_CR36","doi-asserted-by":"publisher","unstructured":"Wei, J. et al. Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third\/booster vaccination or breakthrough infection in the UK general population. Preprint at https:\/\/doi.org\/10.1101\/2022.11.29.22282916 (2022).","DOI":"10.1101\/2022.11.29.22282916"},{"key":"40592_CR37","doi-asserted-by":"publisher","unstructured":"Carazo, S. et al. Prior infection- and\/or vaccine-induced protection against Omicron BA.1, BA.2 and BA.4\/BA.5-related hospitalisations in older adults: a test-negative case-control study in Quebec, Canada. Preprint at https:\/\/doi.org\/10.1101\/2022.12.21.22283740 (2022).","DOI":"10.1101\/2022.12.21.22283740"},{"key":"40592_CR38","doi-asserted-by":"publisher","unstructured":"Arieta, C. M. et al. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection. Cell S0092867423004038 https:\/\/doi.org\/10.1016\/j.cell.2023.04.007 (2023).","DOI":"10.1016\/j.cell.2023.04.007"},{"key":"40592_CR39","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","volume":"184","author":"W Dejnirattisai","year":"2021","unstructured":"Dejnirattisai, W. et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell 184, 2183\u20132200.e22 (2021).","journal-title":"Cell"},{"key":"40592_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.12688\/wellcomeopenres.17143.3","volume":"6","author":"H Colton","year":"2022","unstructured":"Colton, H. et al. Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. Wellcome Open Res. 6, 220 (2022).","journal-title":"Wellcome Open Res."},{"key":"40592_CR41","doi-asserted-by":"publisher","first-page":"D1053","DOI":"10.1093\/nar\/gkac1011","volume":"51","author":"DJ Barker","year":"2023","unstructured":"Barker, D. J. et al. The IPD-IMGT\/HLA Database. Nucleic Acids Res. 51, D1053\u2013D1060 (2023).","journal-title":"Nucleic Acids Res."},{"key":"40592_CR42","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.patter.2020.100178","volume":"2","author":"A Tomic","year":"2021","unstructured":"Tomic, A. et al. SIMON: open-source knowledge discovery platform. Patterns 2, 100178 (2021).","journal-title":"Patterns"},{"key":"40592_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/wics.101","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi, H. & Williams, L. J. Principal component analysis: Principal component analysis. Wiley Interdiscip. Rev. Comput. Stat. 2, 433\u2013459 (2010).","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"key":"40592_CR44","doi-asserted-by":"crossref","unstructured":"Husson, F., L\u00ea, S. & Pag\u00e8s, J. Exploratory Multivariate Analysis by Example Using R. (CRC Press Taylor & Francis Group, 2017).","DOI":"10.1201\/b21874"},{"key":"40592_CR45","doi-asserted-by":"publisher","unstructured":"Hornsby, H. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history-complete clean dataset. https:\/\/doi.org\/10.17605\/OSF.IO\/9TSZ6 (2023).","DOI":"10.17605\/OSF.IO\/9TSZ6"},{"key":"40592_CR46","doi-asserted-by":"publisher","unstructured":"Payne, R. P. RebeccaPPayne\/Omicron-Newcastle: Omicron infections in triple-vaccinated individuals enhance a broad spectrum of mucosal and blood immune responses dependent on prior infection history Newcastle_data_v1.0.0. https:\/\/doi.org\/10.5281\/ZENODO.8045107 (2023).","DOI":"10.5281\/ZENODO.8045107"},{"key":"40592_CR47","doi-asserted-by":"publisher","unstructured":"Payne, R. P. RebeccaPPayne\/Omicron-Sheffield: Omicron infections in triple-vaccinated individuals enhance a broad spectrum of mucosal and blood immune responses dependent on prior infection history Sheffield_data. https:\/\/doi.org\/10.5281\/ZENODO.8045040 (2023).","DOI":"10.5281\/ZENODO.8045040"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40592-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T17:07:08Z","timestamp":1700154428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40592-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40592"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-40592-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.D. is a Scientific Advisor to the Scottish Parliament on COVID-19 for which she receives a fee. Oxford University has entered a joint COVID-19 vaccine development partnership with AstraZeneca. G.S. sits on the GSK Vaccines Scientific Advisory Board and is a founder member of RQ Biotechnology. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5065"}}